{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T13:10:20Z","timestamp":1777468220378,"version":"3.51.4"},"reference-count":34,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2009,8,3]],"date-time":"2009-08-03T00:00:00Z","timestamp":1249257600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Science"],"published-print":{"date-parts":[[2009,11]]},"abstract":"<jats:p>Cholangiocarcinoma (CCA) is a fatal disease with high resistance to anticancer drugs. This is probably in part due to enhanced resistance to apoptosis. We have previously shown that galectin\u20103 (Gal\u20103), a \u03b2\u2010galactoside\u2010binding lectin, is highly expressed in CCA tissues. In this study, we demonstrated further that Gal\u20103 plays a direct role in anti\u2010apoptosis regardless of the apoptotic insults. The anti\u2010apoptotic activity and chemoresistance of CCA cells were related to Gal\u20103 expression level. Suppression of Gal\u20103 expression with siRNA stimulated apoptosis. siGal\u20103\u2010K626 transiently depleted Gal\u20103 expression to the baseline and dramatically induced apoptosis, while siGal\u20103\u2010K402 suppressed Gal\u20103 expression by 50% and provoked cell apoptosis, but only under apoptotic insults (hypoxic conditions or short UV radiation). These actions were reversed in Gal\u20103 overexpressing CCA cells. The correlation between the degree of anti\u2010apoptotic activity and the level of endogenous Gal\u20103 was demonstrated. Suppression of Gal\u20103 expression in CCA cells with siGal\u20103\u2010K402 significantly enhanced apoptosis induced by cisplatin or 5\u2010fluorouracil by approximately 10 times, whereas overexpression of Gal\u20103 led to an increased resistance to drugs. In summary, the present study showed that the cellular level of Gal\u20103 might contribute to the anti\u2010apoptotic activity and chemoresistance of CCA cells. Hence, Gal\u20103 expression level in cancer cells or tissues may be a marker for predicting chemotherapeutic response, and Gal\u20103 may be a specific gene\u2010targeting therapy option for treating CCA. (<jats:italic>Cancer Sci<\/jats:italic> 2009; 00: 000\u2013000)<\/jats:p>","DOI":"10.1111\/j.1349-7006.2009.01304.x","type":"journal-article","created":{"date-parts":[[2009,8,3]],"date-time":"2009-08-03T16:28:21Z","timestamp":1249316901000},"page":"2077-2084","source":"Crossref","is-referenced-by-count":28,"title":["Suppression of galectin\u20103 expression enhances apoptosis and chemosensitivity in liver fluke\u2010associated cholangiocarcinoma"],"prefix":"10.1111","volume":"100","author":[{"given":"Sopit","family":"Wongkham","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mutita","family":"Junking","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chaisiri","family":"Wongkham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Banchob","family":"Sripa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siri","family":"Chur\u2010in","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norie","family":"Araki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,10,11]]},"reference":[{"key":"e_1_2_6_2_2","first-page":"489","article-title":"A high incidence of liver cancer in Khon Kaen Province, Thailand","volume":"21","author":"Vatanasapt V","year":"1990","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910590412"},{"issue":"2","key":"e_1_2_6_4_2","first-page":"ii","article-title":"The role of chemotherapy in cholangiocarcinoma","volume":"16","author":"Thongprasert S","year":"2005","journal-title":"Ann Oncol"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2008.01.014"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(17)31891-4"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1093\/glycob\/3.4.297"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0300-9084(01)01289-5"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1007\/s000180300022"},{"issue":"23","key":"e_1_2_6_10_2","first-page":"5272","article-title":"Galectin\u20103: a novel antiapoptotic molecule with a functional BH1 (NWGR) domain of Bcl\u20102 family","volume":"57","author":"Akahani S","year":"1997","journal-title":"Cancer Res"},{"issue":"16","key":"e_1_2_6_11_2","first-page":"4148","article-title":"Cell cycle arrest and inhibition of anoikis by galectin\u20103 in human breast epithelial cells","volume":"59","author":"Kim HR","year":"1999","journal-title":"Cancer Res"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/21.11.1941"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.93.13.6737"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M107668200"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)64975-9"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v11.i22.3392"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1046-2023(02)00023-3"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1038\/227680a0"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.76.9.4350"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/82.13.1107"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2008.12.153"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.22848"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v11.i18.2748"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)63177-X"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.24.10.4395-4406.2004"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M200154200"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-05-3750"},{"issue":"23","key":"e_1_2_6_28_2","first-page":"8302","article-title":"CD29 and CD7 mediate galectin\u20103\u2010induced type II T\u2010cell apoptosis","volume":"63","author":"Fukumori T","year":"2003","journal-title":"Cancer Res"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-5793(00)01547-7"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-03-2682"},{"issue":"17","key":"e_1_2_6_31_2","first-page":"5198","article-title":"Suppression of BRAF(V599E) in human melanoma abrogates transformation","volume":"63","author":"Hingorani SR","year":"2003","journal-title":"Cancer Res"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1535-6108(02)00122-8"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1093\/glycob\/cwj056"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1593\/neo.07433"},{"issue":"18","key":"e_1_2_6_35_2","doi-asserted-by":"crossref","first-page":"8350","DOI":"10.1158\/0008-5472.CAN-05-0163","article-title":"A novel carbohydrate\u2010based therapeutic GCS\u2010100 overcomes bortezomib resistance and enhances dexamethasone\u2010induced apoptosis in multiple myeloma cells","volume":"65","author":"Chauhan D","year":"2005","journal-title":"Cancer Res"}],"container-title":["Cancer Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1349-7006.2009.01304.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1349-7006.2009.01304.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T02:43:02Z","timestamp":1697424182000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1349-7006.2009.01304.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10,11]]},"references-count":34,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["10.1111\/j.1349-7006.2009.01304.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1349-7006.2009.01304.x","archive":["Portico"],"relation":{},"ISSN":["1347-9032","1349-7006"],"issn-type":[{"value":"1347-9032","type":"print"},{"value":"1349-7006","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,10,11]]}}}